NCT04803201 2026-04-02
Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma
Alliance for Clinical Trials in Oncology
Phase 2 Suspended
Alliance for Clinical Trials in Oncology
SymBio Pharmaceuticals
Myeloid Therapeutics